MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
ESTA stock logo

ESTA

Establishment Labs Holdings Inc.

$58.31
-0.39
 (-0.66%)
Exchange:  NASDAQ
Market Cap:  1.71B
Shares Outstanding:  18.487M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Fillipo Peter Caldini
Full Time Employees:  1034
Address: 
Building B15 and 25
Alajuela
CR
Website:  https://www.establishmentlabs.com
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/10 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue165,151166,025211,076
Gross Profit106,977109,525146,308
EBITDA-58,307-56,222-32,766
Operating Income-65,026-49,987-39,008
Net Income-78,502-84,596-51,064

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets268,641346,831357,167
Total Liabilities250,246293,736333,620
Total Stockholders Equity18,39553,09523,547
Total Debt192,224225,2942,820
Cash and Cash Equivalents40,03590,34775,572

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-88,513-58,5160
Capital Expenditure-24,547-6,1140
Free Cash Flow-113,060-64,6300
Net Income-78,502-84,596-51,064
Net Change in Cash-26,32050,3120

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)666,279.188Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)674,289.556Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)669,700Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)-189,921.665Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)-187,665.450Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)-188,628.962Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)108,873.962Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)110,578.121Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)109,601.777Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)534,720.668Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)541,149.369Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)537,466.032Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)3.700Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)3.730Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)3.680Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)6Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)2Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
166.025M  ?P/S
 (TTM)
: 
9.32
?Net Income
 (TTM)
: 
-84596000  ?P/E
 (TTM)
: 
-38.91
?Enterprise Value
 (TTM)
: 
2.156B  ?EV/FCF
 (TTM)
: 
-37.53
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-2.02  ?ROIC
 (TTM)
: 
-0.12
?Net Debt
 (TTM)
: 
134.947M  ?Debt/Equity
 (TTM)
: 
11.23
?P/B
 (TTM)
: 
84.39  ?Current Ratio
 (TTM)
: 
3.04

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate ESTA Intrinsic Value

Common questions about ESTA valuation

Is Establishment Labs Holdings Inc. (ESTA) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Establishment Labs Holdings Inc. (ESTA) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is ESTA a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ESTA trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is ESTA’s P/E ratio?

You can see ESTA’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for ESTA?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is ESTA a good long-term investment?

Whether ESTA fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

ESTA

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.66
MARKETSnap

Trading Metrics:

Open: 57.77   Previous Close: 58.7
Day Low: 56.98   Day High: 59.02
Year Low: 26.56   Year High: 83.31
Price Avg 50: 68.06   Price Avg 200: 55.55
Volume: 274392   Average Volume: 505082

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
24-04-2026 02:12
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
24-02-2026 12:01
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Establishment Labs (NASDAQ:ESTA) vs. Co-Diagnostics (NASDAQ:CODX) Head to Head Contrast
19-02-2026 03:29
Establishment Labs (NASDAQ:ESTA) vs. Co-Diagnostics (NASDAQ:CODX) Head to Head Contrast
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
14-01-2026 15:56
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction
30-12-2025 13:45
ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
29-12-2025 08:00
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read